[1] 徐冰,史新元,吴志生,等. 论中药质量源于设计[J]. 中国中药杂志,2017,42(6):1015-1024. XU Bing,SHI Xinyuan,WU Zhisheng,et al. Quality by design approaches for pharmaceutical development and manufacturing of Chinese medicine[J]. Chinese Journal of Chinese Materia Medica,2017,42(6):1015-1024.
[2] PETERSON J J. A Bayesian approach to the ICH Q8 definition of design space[J]. Journal of Biopharmaceutical Statistics, 2008,18(5):959.
[3] RATHORE A S. Quality by design (QbD)-based process development for purification of a biotherapeutic[J]. Trends in Biotechnology, 2016,34(5):358-370.
[4] MARTO J,GOUVEIA L F,GONCALVES L M,et al. A quality by design(QbD)approach on starch-based nanocapsules:a promising platform for topical drug delivery[J]. Colloids & Surfaces B:Biointerfaces,2016,143:177.
[5] TROIANO G,NOLAN J,PARSONS D,et al. A quality by design approach to developing and manufacturing polymeric nanoparticle drug products[J]. Aaps Journal,2016,18(6):1354-1365.
[6] GONG X,CHEN H,PAN J,et al. Optimization of Panax notoginseng,extraction process using a design space approach[J]. Separation & Purification Technology,2015,141:197-206.
[7] 戴胜云,徐冰,张毅,等. 质量源于设计(QbD)在药物分析方法开发中的应用研究进展[J]. 药物分析杂志,2016,36(6):950-960. DAI Shengyun,XU Bing,ZHANG Yi,et al. Application progress of quality by design based pharmaceutical analysis method[J]. Chinese Journal of Pharmaceutical Analysis,2016,36(6):950-960.
[8] 徐冰,史新元,乔延江,等. 中药制剂生产工艺设计空间的建立[J]. 中国中药杂志,2013,38(6):924-929. XU Bing,SHI Xinyuan,QIAO Yanjiang,et al. Establishment of design space for production process of traditional Chinese medicine preparation[J]. Chinese Journal of Chinese Materia Medica,2013,38(6):924-929.
[9] 国家药典委员会. 中国药典[M]. 北京:中国医药科技出版社,2015:12. Chinese Pharmacopoeia Commission. Chinese pharmacopoeia[M]. Beijing:China Medical Science Press,2015:12.
[10] 郭林丰,童姗姗,余江南,等. 苦参碱抗肿瘤作用机制研究进展[J]. 中国中药杂志,2013,38(20):3409-3412. GUO Linfeng,TONG Shanshan,YU Jiangnan,et al. Advance in studies on anti-tumor mechanism of matrine[J]. Chinese Journal of Chinese Materia Medica,2013,38(20):3409-3412.
[11] 郭秋平,金若敏. 苦参碱和氧化苦参碱致小鼠肝毒性比较[J]. 中国药理学与毒理学杂志,2016,30(7):736-740. GUO Qiuping,JIN Ruomin. Comparison of liver toxicity of matrine and oxymatrine in mice[J]. Chinese Journal of Pharmacology and Toxicology,2016,30(7):736-740.
[12] LIU Y,XU Y,JI W,et al. Anti-tumor activities of matrine and oxymatrine:literature review[J]. Tumor Biology,2014,35(6):5111.
[13] 徐姗珺,陈长勋,高建平. 甘草与附子配伍减毒的有效成分及作用环节研究[J]. 中成药,2006,28(4):526-530. XU Shanjun,CHEN Changxun,GAO Jianping. Attenuated effect of active components of Radix Glycyrrhizae on Radix Aconiti Laterlis and the related mechanisms[J]. Chinese Traditional Patent Medicine,2006,28(4):526-530.
[14] 孟祥松,时军. 溴甲酚绿比色法测定苦参总碱含量的研究[J]. 安徽医药,2007,11(1):41-42. MENG Xiangsong,SHI Jun. Determination of total matrine concentration by bromocresol green method[J]. Anhui Medical and Pharmaceutical Journal,2007,11(1):41-42.
[15] 赵洋,张涛,贾红梅,等. 苦参-甘草药对提取工艺的优化及其化学成分分析[J]. 中国实验方剂学杂志,2017,23(3):18-24. ZHAO Yang,ZHANG Tao,JIA Hongmei,et al. Optimization of extraction process for couplet medicines of Sophorae Flavescentis Radix-Glycyrrhizae Radix et Rhizoma and identification of its chemical constituents[J]. Chinese Journal of Experimental Traditional Medical Formulae,2017,23(3):18-24.
[16] 宋佳,黄飞龙,段树卿,等. Plackett-Burnman设计联合Box-Behnken设计-效应面法优化心神宁片的提取工艺[J]. 中草药,2016,47(3):430-435. SONG Jia,HUANG Feilong,DUAN Shuqing,et al. Optimization of extraction process for Xinshenning Tablets by Plackeet-Burnman,Box-Behnken,and response surface methodology[J]. Chinese Traditional and Herbal Drugs,2016,47(3):430-435.
[17] 熊道陵,张团结,陈金洲,等. 茶皂素提取及应用研究进展[J]. 化工进展,2015,34(4):1080-1087. XIONG Daoling,ZHANG Tuanjie,CHEN Jinzhou,et al. Research progress in extraction processing and application of tea saponin[J]. Chemical Industry and Engineering Progress,2015,34(4):1080-1087. |